Utilização de omeprazol por pacientes atendidos na rede básica de saúde no município de Santa Cruz do Sul - RS.

Abstract

Proton pump inhibitors (PPIs) are one of the classes used to treat diseases of the digestive tract and have as one of their representatives, omeprazole which is one of the drugs most used for various acid-peptic disorders. It is present in the Unified Health System (SUS) through the Basic Component of Pharmaceutical Assistance, composing the list of the National List of Essential Medicines (RENAME) since 2002. Because it is a highly lipophilic drug, it can affect several pathophysiological pathways and due to this reason, several studies have demonstrated the concern with the safety of the patients who use the drug in the long term. The objective of the study was to evaluate the use of the drug omeprazole by patients attending the public health service. Data were collected from March to April/19 and 75 patients who were waiting before and after treatment were withdrawn from the central and southern pharmacies. Of the total number of respondents, 74.7% were female and 64.0% were over 60 years old. In the last 6 months, the vast majority (77.3%) had consultations in the ESF/UBS of the municipality and 61.3% had examinations before they started using the drug. As for the time of use, 41.3% have used the drug for more than 8 years, 72.0% do not care about the time of use and 66.7% do not know how long they will use. In addition, everyone knows what the medication is for, 82.7% use the medication in the correct dose, and only 8.0% does not follow the frequency of daily use prescribed by the doctor. The results found in the present study contributed in a beneficial way to the identification of the correct use of the drug omeprazole by patients of the public health service of Santa Cruz do Sul. Also, it is essential and extremely important to follow the guidance to users regarding the correct use of this medicine, as well as its duration of use and its real need.